The US Food and Drug Administration (FDA) yesterday approved Wyeth's new drug Torisel (chemical name temsirolimus) for the treatment of renal cell carcinoma, the most common form of advanced kidney cancer.
The FDA approval was based on the results of a clinical trial published today in the New England Journal of Medicine.
The trial showed that patients who were given Torisel alone showed a significant improvement in overall survival of about three and a half months compared with patients who were only on interferon.

Source:  FDA Approves Wyeth's Torisel For Treatment Of Advanced Kidney Cancer


Post a Comment

Google Analytics Alternative